Nice data-driven piece. "Cancer Drug Response Profile scan: A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature" via Chang et al. @Syntekabio Scientific Reports

A study of 128 drugs FDA approved between 2010-2014. "Median initiation was 1974, with a median of 25 years to the established point, 28 years to first clinical trials, and 36 years to FDA approval" via Laura McNamee (Laura McNamee) et al. buff.ly/2JL9DCx PLOS #motivation

Want to work with a multidisciplinary team on the cutting edge of regenerative cell therapies, using microfluidics, automation, and machine learning? Check out our new openings: scaledbiolabs.com/careers.html

Our legendary Lead Scientist Dr. Kelly Haston sharing our vision IndieBio's stem cell Meetup event Stanford University tonight. Let us know if you're about!

Regenerative medicine event tonight with Prellis Biologics Scaled Biolabs Convalesce at Sheppard Mullin in Palo Alto

It was a fantastic "Regenerative Medicine" event last night with Prellis Biologics Scaled Biolabs Convalesce at Sheppard Mullin in Palo Alto. Jun Axup Penman #IndieBio

"Biology first, modality second" Ai Ching Lim Amgen 🧪🔬🧬 in #mbcbiolabs seminar series QB3 today.

Join our #synbiobeta2018 session on how #synbio has become the cutting edge in #pharma & #healthcare w/ @OxfordGenetics, Maria Soloveychik @SyntheX_Labs, David Younger A-Alpha Bio, eGenesis, Melanie Matheu, PhD @PrellisBio @dmtxbio Scaled Biolabs bit.ly/2pi9SbA

Brace for impact. We're proud to kick off #SynBioBeta2018 with an exciting announcement. Be sure to tune in during the "Biopharma & Healthcare" session tomorrow SynBioBeta (Room 1, 1.40pm) to hear our CEO, Drew Titmarsh (@dmtxbio), spill the details. More info coming soon!

We're proud to announce our latest collaboration. Working with Platelet BioGenesis (@PlateletBioGen), we will unlock a robust, economical and streamlined process for making human #Platelets! Details: businesswire.com/news/home/2018…

"The agreement follows a successful pilot program that has boosted the performance economics of a critical stage of #platelet production by almost an order of magnitude." Super excited about our next chapter with @PlateletBioGen (plateletbiogenesis.com) #synbiobeta2018

CEO Drew Titmarsh delivering our approach and @PlateletBioGen announcement SynBioBeta today #synbiobeta2018. Come chat more IndieBio tonight if you're about!

Progress on predicting #protein structures using #AI out of DeepMindAI. "...CASP organizers have called 'unprecedented progress in the ability of computational methods to predict protein structure'". deepmind.com/blog/alphafold/

High-Performance Medicine: my Nature Medicine review of #AI and where we're headed nature.com/articles/s4159… (open-access for 30 days)

"An efficient, scalable manufacturing process is critical". Kicking off this year's #JPM19 Alliance for Regenerative Medicine (ARM) @Celgene

Today we join with 3Scan Prellis Biologics and friends to showcase new cell-focused technologies for biotech globenewswire.com/news-release/2… #JPM19 #JPM2019

Dropped in Cell Stem Cell - Thousands of human cardiac organoids used to discover heart regeneration drugs that don't cause arrythmias... by Scaled friends Richard Mills, James Hudson, @PorrelloER, et al. doi.org/10.1016/j.stem…

Things happening back home! We were excited to host the Chief Scientist of Queensland, Prof Paul Bertsch, at Scaled for a tour and some real talk! Thanks #tradeinvestqueensland #tiq for facilitating!